XML 21 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Interim Condensed Consolidated Statement of Changes In Equity (Unaudited) - USD ($)
$ in Thousands
Total
Ordinary Shares
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Previously Reported
Previously Reported
Ordinary Shares
Previously Reported
Accumulated Other Comprehensive Income (Loss)
Previously Reported
Accumulated Deficit
Revision of Prior Period, Accounting Standards Update, Adjustment
Revision of Prior Period, Accounting Standards Update, Adjustment
Accumulated Deficit
Balance at beginning of the period (in shares) at Dec. 31, 2018   217,526,425       1,646,223        
Balance at beginning of the period at Dec. 31, 2018 $ 1,050,607 $ 1,677,510 $ 5,358 $ (632,261) $ 1,050,607 $ 1,677,510 $ 5,358 $ (632,261)    
Increase (Decrease) in Shareholders' Equity                    
Issuance of ordinary shares, net (in shares)   2                
Share-based award activity 3,176 $ 3,176                
Net loss (59,260)     (59,260)            
Comprehensive loss (3,770)   (3,770)              
Balance at end of the period (in shares) at Mar. 31, 2019   217,526,427                
Balance at end of the period at Mar. 31, 2019 990,753 $ 1,680,686 1,588 (691,521)            
Balance at beginning of the period (in shares) at Dec. 31, 2018   217,526,425       1,646,223        
Balance at beginning of the period at Dec. 31, 2018 1,050,607 $ 1,677,510 5,358 (632,261) $ 1,050,607 $ 1,677,510 $ 5,358 $ (632,261)    
Increase (Decrease) in Shareholders' Equity                    
Net loss (137,021)                  
Comprehensive loss (7,631)                  
Balance at end of the period (in shares) at Jun. 30, 2019   305,268,497                
Balance at end of the period at Jun. 30, 2019 1,356,654 $ 2,128,209 (2,273) (769,282)            
Balance at beginning of the period (in shares) at Mar. 31, 2019   217,526,427                
Balance at beginning of the period at Mar. 31, 2019 990,753 $ 1,680,686 1,588 (691,521)            
Increase (Decrease) in Shareholders' Equity                    
Tax Receivable Agreement (264,600)                  
Issuance of ordinary shares, net (in shares)   7,929                
Issuance of ordinary shares, net 137 $ 137                
Merger capitalization (in shares)   87,749,999                
Merger recapitalization 678,054 $ 678,054                
Share-based award activity 33,932 $ 33,932                
Net loss (77,761)     (77,761)            
Comprehensive loss (3,861)   (3,861)              
Balance at end of the period (in shares) at Jun. 30, 2019   305,268,497                
Balance at end of the period at Jun. 30, 2019 1,356,654 $ 2,128,209 (2,273) (769,282)            
Balance at beginning of the period (in shares) at Dec. 31, 2019   306,874,115                
Balance at beginning of the period at Dec. 31, 2019 1,360,412 $ 2,208,529 (4,879) (843,238)         $ (9,319) $ (9,319)
Increase (Decrease) in Shareholders' Equity                    
Issuance of ordinary shares, net (in shares)   27,600,000                
Issuance of ordinary shares, net 539,714 $ 539,714                
Exercise of public warrants (in shares)   28,880,098                
Exercise of public warrants 277,526 $ 277,526                
Exercise of stock options (in shares)   3,715,455                
Exercise of stock options 1,182 $ 1,182                
Vesting of restricted stock units (in shares)   169,842                
Shares returned to the Company for net share settlements (in shares)   (2,301,458)                
Shares returned to the Company for net share settlements (10,302) $ (10,302)                
Share-based award activity 16,384 $ 16,384                
Net loss (74,001)     (74,001)            
Comprehensive loss (8,470)   (8,470)              
Balance at end of the period (in shares) at Mar. 31, 2020   364,938,052                
Balance at end of the period at Mar. 31, 2020 2,093,126 $ 3,033,033 (13,349) (926,558)            
Balance at beginning of the period (in shares) at Dec. 31, 2019   306,874,115                
Balance at beginning of the period at Dec. 31, 2019 1,360,412 $ 2,208,529 (4,879) (843,238)         $ (9,319) $ (9,319)
Increase (Decrease) in Shareholders' Equity                    
Net loss (75,492)                  
Comprehensive loss (10,750)                  
Balance at end of the period (in shares) at Jun. 30, 2020   387,335,119                
Balance at end of the period at Jun. 30, 2020 2,382,589 $ 3,326,267 (15,629) (928,049)            
Balance at beginning of the period (in shares) at Mar. 31, 2020   364,938,052                
Balance at beginning of the period at Mar. 31, 2020 2,093,126 $ 3,033,033 (13,349) (926,558)            
Increase (Decrease) in Shareholders' Equity                    
Issuance of ordinary shares, net (in shares)   20,982,500                
Issuance of ordinary shares, net 304,030 $ 304,030                
Exercise of stock options (in shares)   3,723,332                
Vesting of restricted stock units (in shares)   2,528                
Shares returned to the Company for net share settlements (in shares)   (2,311,293)                
Shares returned to the Company for net share settlements (15,118) $ (15,118)                
Share-based award activity 4,322 $ 4,322                
Net loss (1,491)     (1,491)            
Comprehensive loss (2,280)   (2,280)              
Balance at end of the period (in shares) at Jun. 30, 2020   387,335,119                
Balance at end of the period at Jun. 30, 2020 $ 2,382,589 $ 3,326,267 $ (15,629) $ (928,049)